Total: £ 56.28
Published Date: 2026-04-10 | Pages: 118 | Tables: 112 | Medical Care
The global Extracellular Vesicles Based Liquid Biopsy market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The North American market for Extracellular Vesicles Based Liquid Biopsy is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Extracellular Vesicles Based Liquid Biopsy is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The global market for Extracellular Vesicles Based Liquid Biopsy in Therapeutic Monitoring is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.
Major global companies of Extracellular Vesicles Based Liquid Biopsy include Bio-Techne, Thermo Fisher Scientific, Qiagen, Exosome Diagnostics, Aethlon Medical, System Biosciences, NanoSomix, Norgen Biotek, Hitachi Chemical, Lonza Group, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Extracellular Vesicles Based Liquid Biopsy market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Extracellular Vesicles Based Liquid Biopsy. The Extracellular Vesicles Based Liquid Biopsy market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Extracellular Vesicles Based Liquid Biopsy market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Extracellular Vesicles Based Liquid Biopsy manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Bio-Techne
Thermo Fisher Scientific
Qiagen
Exosome Diagnostics
Aethlon Medical
System Biosciences
NanoSomix
Norgen Biotek
Hitachi Chemical
Lonza Group
Stemcell Technologies
Aruna Bio
Evomic Science
Izon Science
Exovita Biosciences
Segment by Type
Blood-derived Liquid Biopsy
Urine-derived Liquid Biopsy
Saliva-derived Liquid Biopsy
Other
Segment by Application
Therapeutic Monitoring
Medical Diagnostics
Biological Research
Other
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Extracellular Vesicles Based Liquid Biopsy companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Extracellular Vesicles Based Liquid Biopsy Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Blood-derived Liquid Biopsy
1.2.3 Urine-derived Liquid Biopsy
1.2.4 Saliva-derived Liquid Biopsy
1.2.5 Other
1.3 Market by Application
1.3.1 Global Extracellular Vesicles Based Liquid Biopsy Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Therapeutic Monitoring
1.3.3 Medical Diagnostics
1.3.4 Biological Research
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Extracellular Vesicles Based Liquid Biopsy Market Perspective (2021–2032)
2.2 Global Extracellular Vesicles Based Liquid Biopsy Growth Trends by Region
2.2.1 Global Extracellular Vesicles Based Liquid Biopsy Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Extracellular Vesicles Based Liquid Biopsy Historic Market Size by Region (2021–2026)
2.2.3 Extracellular Vesicles Based Liquid Biopsy Forecasted Market Size by Region (2027–2032)
2.3 Extracellular Vesicles Based Liquid Biopsy Market Dynamics
2.3.1 Extracellular Vesicles Based Liquid Biopsy Industry Trends
2.3.2 Extracellular Vesicles Based Liquid Biopsy Market Drivers
2.3.3 Extracellular Vesicles Based Liquid Biopsy Market Challenges
2.3.4 Extracellular Vesicles Based Liquid Biopsy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Extracellular Vesicles Based Liquid Biopsy Players by Revenue
3.1.1 Global Top Extracellular Vesicles Based Liquid Biopsy Players by Revenue (2021–2026)
3.1.2 Global Extracellular Vesicles Based Liquid Biopsy Revenue Market Share by Players (2021–2026)
3.2 Global Top Extracellular Vesicles Based Liquid Biopsy Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Extracellular Vesicles Based Liquid Biopsy Revenue
3.4 Global Extracellular Vesicles Based Liquid Biopsy Market Concentration Ratio
3.4.1 Global Extracellular Vesicles Based Liquid Biopsy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Extracellular Vesicles Based Liquid Biopsy Revenue in 2025
3.5 Global Key Players of Extracellular Vesicles Based Liquid Biopsy Head Offices and Areas Served
3.6 Global Key Players of Extracellular Vesicles Based Liquid Biopsy, Products and Applications
3.7 Global Key Players of Extracellular Vesicles Based Liquid Biopsy, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Extracellular Vesicles Based Liquid Biopsy Breakdown Data by Type
4.1 Global Extracellular Vesicles Based Liquid Biopsy Historic Market Size by Type (2021–2026)
4.2 Global Extracellular Vesicles Based Liquid Biopsy Forecasted Market Size by Type (2027–2032)
5 Extracellular Vesicles Based Liquid Biopsy Breakdown Data by Application
5.1 Global Extracellular Vesicles Based Liquid Biopsy Historic Market Size by Application (2021–2026)
5.2 Global Extracellular Vesicles Based Liquid Biopsy Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Extracellular Vesicles Based Liquid Biopsy Market Size (2021–2032)
6.2 North America Extracellular Vesicles Based Liquid Biopsy Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Extracellular Vesicles Based Liquid Biopsy Market Size by Country (2021–2026)
6.4 North America Extracellular Vesicles Based Liquid Biopsy Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Extracellular Vesicles Based Liquid Biopsy Market Size (2021–2032)
7.2 Europe Extracellular Vesicles Based Liquid Biopsy Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Extracellular Vesicles Based Liquid Biopsy Market Size by Country (2021–2026)
7.4 Europe Extracellular Vesicles Based Liquid Biopsy Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Extracellular Vesicles Based Liquid Biopsy Market Size (2021–2032)
8.2 Asia-Pacific Extracellular Vesicles Based Liquid Biopsy Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Extracellular Vesicles Based Liquid Biopsy Market Size by Region (2021–2026)
8.4 Asia-Pacific Extracellular Vesicles Based Liquid Biopsy Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Extracellular Vesicles Based Liquid Biopsy Market Size (2021–2032)
9.2 Latin America Extracellular Vesicles Based Liquid Biopsy Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Extracellular Vesicles Based Liquid Biopsy Market Size by Country (2021–2026)
9.4 Latin America Extracellular Vesicles Based Liquid Biopsy Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Extracellular Vesicles Based Liquid Biopsy Market Size (2021–2032)
10.2 Middle East & Africa Extracellular Vesicles Based Liquid Biopsy Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Extracellular Vesicles Based Liquid Biopsy Market Size by Country (2021–2026)
10.4 Middle East & Africa Extracellular Vesicles Based Liquid Biopsy Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bio-Techne
11.1.1 Bio-Techne Company Details
11.1.2 Bio-Techne Business Overview
11.1.3 Bio-Techne Extracellular Vesicles Based Liquid Biopsy Introduction
11.1.4 Bio-Techne Revenue in Extracellular Vesicles Based Liquid Biopsy Business (2021–2026)
11.1.5 Bio-Techne Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Extracellular Vesicles Based Liquid Biopsy Introduction
11.2.4 Thermo Fisher Scientific Revenue in Extracellular Vesicles Based Liquid Biopsy Business (2021–2026)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Qiagen
11.3.1 Qiagen Company Details
11.3.2 Qiagen Business Overview
11.3.3 Qiagen Extracellular Vesicles Based Liquid Biopsy Introduction
11.3.4 Qiagen Revenue in Extracellular Vesicles Based Liquid Biopsy Business (2021–2026)
11.3.5 Qiagen Recent Development
11.4 Exosome Diagnostics
11.4.1 Exosome Diagnostics Company Details
11.4.2 Exosome Diagnostics Business Overview
11.4.3 Exosome Diagnostics Extracellular Vesicles Based Liquid Biopsy Introduction
11.4.4 Exosome Diagnostics Revenue in Extracellular Vesicles Based Liquid Biopsy Business (2021–2026)
11.4.5 Exosome Diagnostics Recent Development
11.5 Aethlon Medical
11.5.1 Aethlon Medical Company Details
11.5.2 Aethlon Medical Business Overview
11.5.3 Aethlon Medical Extracellular Vesicles Based Liquid Biopsy Introduction
11.5.4 Aethlon Medical Revenue in Extracellular Vesicles Based Liquid Biopsy Business (2021–2026)
11.5.5 Aethlon Medical Recent Development
11.6 System Biosciences
11.6.1 System Biosciences Company Details
11.6.2 System Biosciences Business Overview
11.6.3 System Biosciences Extracellular Vesicles Based Liquid Biopsy Introduction
11.6.4 System Biosciences Revenue in Extracellular Vesicles Based Liquid Biopsy Business (2021–2026)
11.6.5 System Biosciences Recent Development
11.7 NanoSomix
11.7.1 NanoSomix Company Details
11.7.2 NanoSomix Business Overview
11.7.3 NanoSomix Extracellular Vesicles Based Liquid Biopsy Introduction
11.7.4 NanoSomix Revenue in Extracellular Vesicles Based Liquid Biopsy Business (2021–2026)
11.7.5 NanoSomix Recent Development
11.8 Norgen Biotek
11.8.1 Norgen Biotek Company Details
11.8.2 Norgen Biotek Business Overview
11.8.3 Norgen Biotek Extracellular Vesicles Based Liquid Biopsy Introduction
11.8.4 Norgen Biotek Revenue in Extracellular Vesicles Based Liquid Biopsy Business (2021–2026)
11.8.5 Norgen Biotek Recent Development
11.9 Hitachi Chemical
11.9.1 Hitachi Chemical Company Details
11.9.2 Hitachi Chemical Business Overview
11.9.3 Hitachi Chemical Extracellular Vesicles Based Liquid Biopsy Introduction
11.9.4 Hitachi Chemical Revenue in Extracellular Vesicles Based Liquid Biopsy Business (2021–2026)
11.9.5 Hitachi Chemical Recent Development
11.10 Lonza Group
11.10.1 Lonza Group Company Details
11.10.2 Lonza Group Business Overview
11.10.3 Lonza Group Extracellular Vesicles Based Liquid Biopsy Introduction
11.10.4 Lonza Group Revenue in Extracellular Vesicles Based Liquid Biopsy Business (2021–2026)
11.10.5 Lonza Group Recent Development
11.11 Stemcell Technologies
11.11.1 Stemcell Technologies Company Details
11.11.2 Stemcell Technologies Business Overview
11.11.3 Stemcell Technologies Extracellular Vesicles Based Liquid Biopsy Introduction
11.11.4 Stemcell Technologies Revenue in Extracellular Vesicles Based Liquid Biopsy Business (2021–2026)
11.11.5 Stemcell Technologies Recent Development
11.12 Aruna Bio
11.12.1 Aruna Bio Company Details
11.12.2 Aruna Bio Business Overview
11.12.3 Aruna Bio Extracellular Vesicles Based Liquid Biopsy Introduction
11.12.4 Aruna Bio Revenue in Extracellular Vesicles Based Liquid Biopsy Business (2021–2026)
11.12.5 Aruna Bio Recent Development
11.13 Evomic Science
11.13.1 Evomic Science Company Details
11.13.2 Evomic Science Business Overview
11.13.3 Evomic Science Extracellular Vesicles Based Liquid Biopsy Introduction
11.13.4 Evomic Science Revenue in Extracellular Vesicles Based Liquid Biopsy Business (2021–2026)
11.13.5 Evomic Science Recent Development
11.14 Izon Science
11.14.1 Izon Science Company Details
11.14.2 Izon Science Business Overview
11.14.3 Izon Science Extracellular Vesicles Based Liquid Biopsy Introduction
11.14.4 Izon Science Revenue in Extracellular Vesicles Based Liquid Biopsy Business (2021–2026)
11.14.5 Izon Science Recent Development
11.15 Exovita Biosciences
11.15.1 Exovita Biosciences Company Details
11.15.2 Exovita Biosciences Business Overview
11.15.3 Exovita Biosciences Extracellular Vesicles Based Liquid Biopsy Introduction
11.15.4 Exovita Biosciences Revenue in Extracellular Vesicles Based Liquid Biopsy Business (2021–2026)
11.15.5 Exovita Biosciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Extracellular Vesicles Based Liquid Biopsy Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Blood-derived Liquid Biopsy
Table 3. Key Players of Urine-derived Liquid Biopsy
Table 4. Key Players of Saliva-derived Liquid Biopsy
Table 5. Key Players of Other
Table 6. Global Extracellular Vesicles Based Liquid Biopsy Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 7. Global Extracellular Vesicles Based Liquid Biopsy Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 8. Global Extracellular Vesicles Based Liquid Biopsy Market Size by Region (US$ Million), 2021–2026
Table 9. Global Extracellular Vesicles Based Liquid Biopsy Market Share by Region (2021–2026)
Table 10. Global Extracellular Vesicles Based Liquid Biopsy Forecasted Market Size by Region (US$ Million), 2027–2032
Table 11. Global Extracellular Vesicles Based Liquid Biopsy Market Share by Region (2027–2032)
Table 12. Extracellular Vesicles Based Liquid Biopsy Market Trends
Table 13. Extracellular Vesicles Based Liquid Biopsy Market Drivers
Table 14. Extracellular Vesicles Based Liquid Biopsy Market Challenges
Table 15. Extracellular Vesicles Based Liquid Biopsy Market Restraints
Table 16. Global Extracellular Vesicles Based Liquid Biopsy Revenue by Players (US$ Million), 2021–2026
Table 17. Global Extracellular Vesicles Based Liquid Biopsy Market Share by Players (2021–2026)
Table 18. Global Top Extracellular Vesicles Based Liquid Biopsy Players by Tier (Tier 1, Tier 2, and Tier 3), based on Extracellular Vesicles Based Liquid Biopsy Revenue, 2025
Table 19. Ranking of Global Top Extracellular Vesicles Based Liquid Biopsy Companies by Revenue (US$ Million) in 2025
Table 20. Global 5 Largest Players Market Share by Extracellular Vesicles Based Liquid Biopsy Revenue (CR5 and HHI), 2021–2026
Table 21. Global Key Players of Extracellular Vesicles Based Liquid Biopsy, Headquarters and Area Served
Table 22. Global Key Players of Extracellular Vesicles Based Liquid Biopsy, Products and Applications
Table 23. Global Key Players of Extracellular Vesicles Based Liquid Biopsy, Date of General Availability (GA)
Table 24. Mergers and Acquisitions, Expansion Plans
Table 25. Global Extracellular Vesicles Based Liquid Biopsy Market Size by Type (US$ Million), 2021–2026
Table 26. Global Extracellular Vesicles Based Liquid Biopsy Revenue Market Share by Type (2021–2026)
Table 27. Global Extracellular Vesicles Based Liquid Biopsy Forecasted Market Size by Type (US$ Million), 2027–2032
Table 28. Global Extracellular Vesicles Based Liquid Biopsy Revenue Market Share by Type (2027–2032)
Table 29. Global Extracellular Vesicles Based Liquid Biopsy Market Size by Application (US$ Million), 2021–2026
Table 30. Global Extracellular Vesicles Based Liquid Biopsy Revenue Market Share by Application (2021–2026)
Table 31. Global Extracellular Vesicles Based Liquid Biopsy Forecasted Market Size by Application (US$ Million), 2027–2032
Table 32. Global Extracellular Vesicles Based Liquid Biopsy Revenue Market Share by Application (2027–2032)
Table 33. North America Extracellular Vesicles Based Liquid Biopsy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 34. North America Extracellular Vesicles Based Liquid Biopsy Market Size by Country (US$ Million), 2021–2026
Table 35. North America Extracellular Vesicles Based Liquid Biopsy Market Size by Country (US$ Million), 2027–2032
Table 36. Europe Extracellular Vesicles Based Liquid Biopsy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 37. Europe Extracellular Vesicles Based Liquid Biopsy Market Size by Country (US$ Million), 2021–2026
Table 38. Europe Extracellular Vesicles Based Liquid Biopsy Market Size by Country (US$ Million), 2027–2032
Table 39. Asia-Pacific Extracellular Vesicles Based Liquid Biopsy Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 40. Asia-Pacific Extracellular Vesicles Based Liquid Biopsy Market Size by Region (US$ Million), 2021–2026
Table 41. Asia-Pacific Extracellular Vesicles Based Liquid Biopsy Market Size by Region (US$ Million), 2027–2032
Table 42. Latin America Extracellular Vesicles Based Liquid Biopsy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 43. Latin America Extracellular Vesicles Based Liquid Biopsy Market Size by Country (US$ Million), 2021–2026
Table 44. Latin America Extracellular Vesicles Based Liquid Biopsy Market Size by Country (US$ Million), 2027–2032
Table 45. Middle East & Africa Extracellular Vesicles Based Liquid Biopsy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 46. Middle East & Africa Extracellular Vesicles Based Liquid Biopsy Market Size by Country (US$ Million), 2021–2026
Table 47. Middle East & Africa Extracellular Vesicles Based Liquid Biopsy Market Size by Country (US$ Million), 2027–2032
Table 48. Bio-Techne Company Details
Table 49. Bio-Techne Business Overview
Table 50. Bio-Techne Extracellular Vesicles Based Liquid Biopsy Product
Table 51. Bio-Techne Revenue in Extracellular Vesicles Based Liquid Biopsy Business (US$ Million), 2021–2026
Table 52. Bio-Techne Recent Development
Table 53. Thermo Fisher Scientific Company Details
Table 54. Thermo Fisher Scientific Business Overview
Table 55. Thermo Fisher Scientific Extracellular Vesicles Based Liquid Biopsy Product
Table 56. Thermo Fisher Scientific Revenue in Extracellular Vesicles Based Liquid Biopsy Business (US$ Million), 2021–2026
Table 57. Thermo Fisher Scientific Recent Development
Table 58. Qiagen Company Details
Table 59. Qiagen Business Overview
Table 60. Qiagen Extracellular Vesicles Based Liquid Biopsy Product
Table 61. Qiagen Revenue in Extracellular Vesicles Based Liquid Biopsy Business (US$ Million), 2021–2026
Table 62. Qiagen Recent Development
Table 63. Exosome Diagnostics Company Details
Table 64. Exosome Diagnostics Business Overview
Table 65. Exosome Diagnostics Extracellular Vesicles Based Liquid Biopsy Product
Table 66. Exosome Diagnostics Revenue in Extracellular Vesicles Based Liquid Biopsy Business (US$ Million), 2021–2026
Table 67. Exosome Diagnostics Recent Development
Table 68. Aethlon Medical Company Details
Table 69. Aethlon Medical Business Overview
Table 70. Aethlon Medical Extracellular Vesicles Based Liquid Biopsy Product
Table 71. Aethlon Medical Revenue in Extracellular Vesicles Based Liquid Biopsy Business (US$ Million), 2021–2026
Table 72. Aethlon Medical Recent Development
Table 73. System Biosciences Company Details
Table 74. System Biosciences Business Overview
Table 75. System Biosciences Extracellular Vesicles Based Liquid Biopsy Product
Table 76. System Biosciences Revenue in Extracellular Vesicles Based Liquid Biopsy Business (US$ Million), 2021–2026
Table 77. System Biosciences Recent Development
Table 78. NanoSomix Company Details
Table 79. NanoSomix Business Overview
Table 80. NanoSomix Extracellular Vesicles Based Liquid Biopsy Product
Table 81. NanoSomix Revenue in Extracellular Vesicles Based Liquid Biopsy Business (US$ Million), 2021–2026
Table 82. NanoSomix Recent Development
Table 83. Norgen Biotek Company Details
Table 84. Norgen Biotek Business Overview
Table 85. Norgen Biotek Extracellular Vesicles Based Liquid Biopsy Product
Table 86. Norgen Biotek Revenue in Extracellular Vesicles Based Liquid Biopsy Business (US$ Million), 2021–2026
Table 87. Norgen Biotek Recent Development
Table 88. Hitachi Chemical Company Details
Table 89. Hitachi Chemical Business Overview
Table 90. Hitachi Chemical Extracellular Vesicles Based Liquid Biopsy Product
Table 91. Hitachi Chemical Revenue in Extracellular Vesicles Based Liquid Biopsy Business (US$ Million), 2021–2026
Table 92. Hitachi Chemical Recent Development
Table 93. Lonza Group Company Details
Table 94. Lonza Group Business Overview
Table 95. Lonza Group Extracellular Vesicles Based Liquid Biopsy Product
Table 96. Lonza Group Revenue in Extracellular Vesicles Based Liquid Biopsy Business (US$ Million), 2021–2026
Table 97. Lonza Group Recent Development
Table 98. Stemcell Technologies Company Details
Table 99. Stemcell Technologies Business Overview
Table 100. Stemcell Technologies Extracellular Vesicles Based Liquid Biopsy Product
Table 101. Stemcell Technologies Revenue in Extracellular Vesicles Based Liquid Biopsy Business (US$ Million), 2021–2026
Table 102. Stemcell Technologies Recent Development
Table 103. Aruna Bio Company Details
Table 104. Aruna Bio Business Overview
Table 105. Aruna Bio Extracellular Vesicles Based Liquid Biopsy Product
Table 106. Aruna Bio Revenue in Extracellular Vesicles Based Liquid Biopsy Business (US$ Million), 2021–2026
Table 107. Aruna Bio Recent Development
Table 108. Evomic Science Company Details
Table 109. Evomic Science Business Overview
Table 110. Evomic Science Extracellular Vesicles Based Liquid Biopsy Product
Table 111. Evomic Science Revenue in Extracellular Vesicles Based Liquid Biopsy Business (US$ Million), 2021–2026
Table 112. Evomic Science Recent Development
Table 113. Izon Science Company Details
Table 114. Izon Science Business Overview
Table 115. Izon Science Extracellular Vesicles Based Liquid Biopsy Product
Table 116. Izon Science Revenue in Extracellular Vesicles Based Liquid Biopsy Business (US$ Million), 2021–2026
Table 117. Izon Science Recent Development
Table 118. Exovita Biosciences Company Details
Table 119. Exovita Biosciences Business Overview
Table 120. Exovita Biosciences Extracellular Vesicles Based Liquid Biopsy Product
Table 121. Exovita Biosciences Revenue in Extracellular Vesicles Based Liquid Biopsy Business (US$ Million), 2021–2026
Table 122. Exovita Biosciences Recent Development
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. Authors List of This Report
List of Figures
Figure 1. Extracellular Vesicles Based Liquid Biopsy Picture
Figure 2. Global Extracellular Vesicles Based Liquid Biopsy Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Extracellular Vesicles Based Liquid Biopsy Market Share by Type: 2025 vs 2032
Figure 4. Blood-derived Liquid Biopsy Features
Figure 5. Urine-derived Liquid Biopsy Features
Figure 6. Saliva-derived Liquid Biopsy Features
Figure 7. Other Features
Figure 8. Global Extracellular Vesicles Based Liquid Biopsy Market Size by Application (US$ Million), 2021–2032
Figure 9. Global Extracellular Vesicles Based Liquid Biopsy Market Share by Application: 2025 vs 2032
Figure 10. Therapeutic Monitoring Case Studies
Figure 11. Medical Diagnostics Case Studies
Figure 12. Biological Research Case Studies
Figure 13. Other Case Studies
Figure 14. Extracellular Vesicles Based Liquid Biopsy Report Years Considered
Figure 15. Global Extracellular Vesicles Based Liquid Biopsy Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 16. Global Extracellular Vesicles Based Liquid Biopsy Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 17. Global Extracellular Vesicles Based Liquid Biopsy Market Share by Region: 2025 vs 2032
Figure 18. Global Extracellular Vesicles Based Liquid Biopsy Market Share by Players in 2025
Figure 19. Global Extracellular Vesicles Based Liquid Biopsy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 20. The Top 10 and 5 Players Market Share by Extracellular Vesicles Based Liquid Biopsy Revenue in 2025
Figure 21. North America Extracellular Vesicles Based Liquid Biopsy Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. North America Extracellular Vesicles Based Liquid Biopsy Market Share by Country (2021–2032)
Figure 23. United States Extracellular Vesicles Based Liquid Biopsy Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Canada Extracellular Vesicles Based Liquid Biopsy Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. Europe Extracellular Vesicles Based Liquid Biopsy Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. Europe Extracellular Vesicles Based Liquid Biopsy Market Share by Country (2021–2032)
Figure 27. Germany Extracellular Vesicles Based Liquid Biopsy Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. France Extracellular Vesicles Based Liquid Biopsy Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. U.K. Extracellular Vesicles Based Liquid Biopsy Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Italy Extracellular Vesicles Based Liquid Biopsy Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Russia Extracellular Vesicles Based Liquid Biopsy Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Ireland Extracellular Vesicles Based Liquid Biopsy Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Asia-Pacific Extracellular Vesicles Based Liquid Biopsy Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Asia-Pacific Extracellular Vesicles Based Liquid Biopsy Market Share by Region (2021–2032)
Figure 35. China Extracellular Vesicles Based Liquid Biopsy Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Japan Extracellular Vesicles Based Liquid Biopsy Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. South Korea Extracellular Vesicles Based Liquid Biopsy Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Southeast Asia Extracellular Vesicles Based Liquid Biopsy Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. India Extracellular Vesicles Based Liquid Biopsy Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Australia & New Zealand Extracellular Vesicles Based Liquid Biopsy Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Latin America Extracellular Vesicles Based Liquid Biopsy Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Latin America Extracellular Vesicles Based Liquid Biopsy Market Share by Country (2021–2032)
Figure 43. Mexico Extracellular Vesicles Based Liquid Biopsy Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Brazil Extracellular Vesicles Based Liquid Biopsy Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Middle East & Africa Extracellular Vesicles Based Liquid Biopsy Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Middle East & Africa Extracellular Vesicles Based Liquid Biopsy Market Share by Country (2021–2032)
Figure 47. Israel Extracellular Vesicles Based Liquid Biopsy Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. Saudi Arabia Extracellular Vesicles Based Liquid Biopsy Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. UAE Extracellular Vesicles Based Liquid Biopsy Market Size YoY Growth (US$ Million), 2021–2032
Figure 50. Bio-Techne Revenue Growth Rate in Extracellular Vesicles Based Liquid Biopsy Business (2021–2026)
Figure 51. Thermo Fisher Scientific Revenue Growth Rate in Extracellular Vesicles Based Liquid Biopsy Business (2021–2026)
Figure 52. Qiagen Revenue Growth Rate in Extracellular Vesicles Based Liquid Biopsy Business (2021–2026)
Figure 53. Exosome Diagnostics Revenue Growth Rate in Extracellular Vesicles Based Liquid Biopsy Business (2021–2026)
Figure 54. Aethlon Medical Revenue Growth Rate in Extracellular Vesicles Based Liquid Biopsy Business (2021–2026)
Figure 55. System Biosciences Revenue Growth Rate in Extracellular Vesicles Based Liquid Biopsy Business (2021–2026)
Figure 56. NanoSomix Revenue Growth Rate in Extracellular Vesicles Based Liquid Biopsy Business (2021–2026)
Figure 57. Norgen Biotek Revenue Growth Rate in Extracellular Vesicles Based Liquid Biopsy Business (2021–2026)
Figure 58. Hitachi Chemical Revenue Growth Rate in Extracellular Vesicles Based Liquid Biopsy Business (2021–2026)
Figure 59. Lonza Group Revenue Growth Rate in Extracellular Vesicles Based Liquid Biopsy Business (2021–2026)
Figure 60. Stemcell Technologies Revenue Growth Rate in Extracellular Vesicles Based Liquid Biopsy Business (2021–2026)
Figure 61. Aruna Bio Revenue Growth Rate in Extracellular Vesicles Based Liquid Biopsy Business (2021–2026)
Figure 62. Evomic Science Revenue Growth Rate in Extracellular Vesicles Based Liquid Biopsy Business (2021–2026)
Figure 63. Izon Science Revenue Growth Rate in Extracellular Vesicles Based Liquid Biopsy Business (2021–2026)
Figure 64. Exovita Biosciences Revenue Growth Rate in Extracellular Vesicles Based Liquid Biopsy Business (2021–2026)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed